Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416973 · ClinicalTrials.gov registry record · NA
Study of PEMF (Pulsed Electromagnetic Field) Therapy in the Treatment of Persistent Post-Operative Pain Following Lumbar Surgery
A NA study of Lumbar Surgery, sponsored by Regenesis Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 8
- Study locations
NCT02416973 is a NA study of Lumbar Surgery that has completed, run by Regenesis Biomedical. The registered enrollment target is 41 participants. The trial reports 8 study locations across 8 states.
The verdict
NCT02416973, a NA study of Lumbar Surgery, has completed, sponsored by Regenesis Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 8
- Study locations
Study Summary
To demonstrate the analgesic effectiveness of 2 modalities of PEMF treatment compared to sham treatment in patients with persistent pain following lumbar surgery when treatment is administered twice daily over a 60 day period.
Conditions Studied
Interventions
- DEVICE Provant
Study Locations (8)
Alabama
- AOC-Research - Birmingham
Arizona
- Hope Research - Phoenix
Idaho
- Injury Care Research - Boise
Illinois
- Rockford Orthopedic - Rockford
Nevada
- Hope Research_Las Vegas - Las Vegas
North Carolina
- Tarheel Clinical Research - Raliegh
South Carolina
- Upstate Clinical - Spartanburg
Virginia
- Danville Orthopedic - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02416973
The ClinicalTrials.gov registry entry for NCT02416973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenesis Biomedical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lumbar Surgery appearing as the primary indexed condition, and to 1 intervention - of which Provant is the first listed.
NCT02416973 reports 8 study locations spanning 8 distinct geographic areas - top geographies include Alabama, Arizona, Idaho.
Frequently Asked Questions
What is clinical trial NCT02416973 about?
NCT02416973 is a clinical study titled "Study of PEMF (Pulsed Electromagnetic Field) Therapy in the Treatment of Persistent Post-Operative Pain Following Lumbar Surgery". To demonstrate the analgesic effectiveness of 2 modalities of PEMF treatment compared to sham treatment in patients with persistent pain following lumbar surgery when treatment is administered twice daily over a 60 day period.
What is the current status of trial NCT02416973?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-03. Estimated completion is 2016-08.
What conditions does trial NCT02416973 study?
This clinical trial studies the following conditions: Lumbar Surgery.
What interventions are being tested in trial NCT02416973?
The interventions under investigation include: Provant (DEVICE).
Who is sponsoring clinical trial NCT02416973?
This trial is sponsored by Regenesis Biomedical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02416973 being conducted?
This trial has 8 study locations across Alabama, Arizona, Idaho, Illinois, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.